Virtus Investment Advisers’s AnaptysBio ANAB Stock Holding History

Virtus Investment Advisers’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$394K	Sell	5,835 -232	-4%	-$14.1K	0.09%	285
2026 Q1	$336K	Buy	6,067 +148	+3%	+$7.96K	0.09%	263
2025 Q4	$287K	Buy	5,919 +1,059	+22%	+$41.3K	0.08%	263
2025 Q3	$149K	Buy	4,860 +843	+21%	+$19.3K	0.04%	375
2025 Q2	$89.2K	Sell	4,017 -6,909	-63%	-$145K	0.03%	386
2025 Q1	$203K	Buy	+10,926	New	+$182K	0.06%	262

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Virtus Investment Advisers's ANAB Position: Q2 2026 in Review

Virtus Investment Advisers reduced its AnaptysBio (ANAB) stake by 3.8% in Q2 2026, selling an estimated $14.1K and leaving 5,835 shares worth $394K. The position accounts for 0.09% of the portfolio, ranked #285.

Virtus Investment Advisers first reported a position in ANAB in Q1 2025 and has held it in 6 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Virtus Investment Advisers held 5,835 shares of AnaptysBio worth $394K as of Q2 2026.
Virtus Investment Advisers sold 232 AnaptysBio shares in Q2 2026, an estimated $14.1K.
AnaptysBio made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #285 holding.
Virtus Investment Advisers first reported a position in AnaptysBio in Q1 2025 and has held it in 6 quarters since.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.